Kura Oncology (KURA) Total Debt (2014 - 2026)
Kura Oncology (KURA) reported Total Debt of $9.7 million for Q1 2026, up 1.86% year-over-year from $9.6 million in Q1 2025, and little changed quarter-over-quarter from $9.7 million in Q4 2025.
Kura Oncology (KURA) Total Debt (2014 - 2026) Analysis & Trends
Kura Oncology (KURA) has 13 years of Total Debt data on file, last reported at $9.7 million in Q1 2026.
- Total Debt for Q1 2026 came in at $9.7 million, up 1.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.7 million (up 1.86% YoY), and the FY2025 annual result was $9.7 million, up 1.97% from the prior year.
- Total Debt was little changed at $9.7 million in Q1 2026 per KURA's latest filing, from $9.7 million in the prior quarter.
- Over five years, Total Debt peaked at $9.7 million in Q1 2026 and troughed at $9.2 million in Q4 2022.
- A 5-year average of $9.5 million and a median of $9.4 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2025 and 2026: Total Debt advanced 2.12% in 2025, then gained 1.86% in 2026.
- A 5-year view of Total Debt shows it stood at $9.2 million in 2022, then rose by 1.9% to $9.3 million in 2023, then gained by 2.05% to $9.5 million in 2024, then advanced by 1.97% to $9.7 million in 2025, then rose by 0.39% to $9.7 million in 2026.
- Business Quant data shows KURA's Total Debt at $9.7 million in Q1 2026, $9.7 million in Q4 2025, and $9.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | 9.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.75 Mn |
| Dec 31, 2025 | 9.71 Mn |
| Sep 30, 2025 | 9.67 Mn |
| Jun 30, 2025 | 9.62 Mn |
| Mar 31, 2025 | 9.57 Mn |
| Dec 31, 2024 | 9.52 Mn |
| Sep 30, 2024 | 9.47 Mn |
| Jun 30, 2024 | 9.42 Mn |
| Mar 31, 2024 | 9.38 Mn |
| Dec 31, 2023 | 9.33 Mn |
| Sep 30, 2023 | 9.29 Mn |
| Jun 30, 2023 | 9.24 Mn |
| Mar 31, 2023 | 9.20 Mn |
| Dec 31, 2022 | 9.16 Mn |
| Mar 31, 2021 | 6.50 Mn |
| Dec 31, 2020 | 7.25 Mn |
| Sep 30, 2020 | 7.50 Mn |
| Jun 30, 2020 | 7.50 Mn |
| Mar 31, 2020 | 7.50 Mn |
| Dec 31, 2019 | 7.50 Mn |